tirzepatide surpass 5

tirzepatide surpass 5 Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) Changes in HbA1c from baseline

Name: tirzepatide surpass 5 Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) Changes in HbA1c from baseline
Brand: actil.am
SKU: 7249858706
Price: 26.78 USD
Availability: InStock
Rating: 4 (18 reviews)

SKU: 7249858706

4.0

USD26.78 USD59.78

Pay in 4 interest-free payments of $6.70 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

At 10 mg/mL: 50 units

Your medical history, current medications, and lifestyle habits allow your provider to tailor-make your plan

Lyophilized storage Unreconstituted GHK-CU powder remains stable longest

6 CT-868, an investigational, once-daily, subcutaneously injected dual GLP-1/GIP receptor agonist currently in Phase II with the potential to be a first in class treatment for glycaemic control as an adjunct to insulin in patients living with type 1 diabetes